Gilead Sciences

NASDAQ

GILD

Stock

Yield per half year: +8.08%
Dividend yield: 3.17%
Sector: Healthcare

News

Gilead Sciences ( GILD ) Beats Stock Market Upswing: What Investors Need to Know

27 june 21:50 Gilead Sciences ( GILD ) Beats Stock Market Upswing: What Investors Need to Know

44 Public Companies Make Time's Most Influential List: Coinbase, UFC, Nintendo, Netflix And More Stocks Investors Can Buy - Abbott Laboratories ( NYSE:ABT ) , Amazon.com ( NASDAQ:AMZN )

27 june 15:39 44 Public Companies Make Time's Most Influential List: Coinbase, UFC, Nintendo, Netflix And More Stocks Investors Can Buy - Abbott Laboratories ( NYSE:ABT ) , Amazon.com ( NASDAQ:AMZN )

Gilead Sciences, Inc. ( GILD ) Is a Trending Stock: Facts to Know Before Betting on It

27 june 13:00 Gilead Sciences, Inc. ( GILD ) Is a Trending Stock: Facts to Know Before Betting on It

KYMR Collaborates With GILD; Stock Down on Sanofi Deal Update

26 june 12:40 KYMR Collaborates With GILD; Stock Down on Sanofi Deal Update

Gilead Sciences ( GILD ) Stock Moves -1.18%: What You Should Know

25 june 22:00 Gilead Sciences ( GILD ) Stock Moves -1.18%: What You Should Know

Gilead Bets On Kymera's CDK2 Molecular Glue Degrader For New Cancer Therapies - Gilead Sciences ( NASDAQ:GILD ) , Sanofi ( NASDAQ:SNY )

25 june 13:23 Gilead Bets On Kymera's CDK2 Molecular Glue Degrader For New Cancer Therapies - Gilead Sciences ( NASDAQ:GILD ) , Sanofi ( NASDAQ:SNY )

25 june 13:00 Aisera Named to Inc.'s 2025 Best Workplaces List

Assembly Biosciences Reports Positive Topline Results from Phase 1b Clinical Trial of Next-Generation Investigational Capsid Assembly Modulator ABI-4334 in Chronic Hepatitis B

25 june 12:00 Assembly Biosciences Reports Positive Topline Results from Phase 1b Clinical Trial of Next-Generation Investigational Capsid Assembly Modulator ABI-4334 in Chronic Hepatitis B

EMA Accepts GSK's Filing for Linerixibat in Rare Disease-Related Itch

24 june 16:15 EMA Accepts GSK's Filing for Linerixibat in Rare Disease-Related Itch

If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today - Gilead Sciences ( NASDAQ:GILD )

23 june 21:15 If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today - Gilead Sciences ( NASDAQ:GILD )